BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 25960330)

  • 1. Effect of different intestinal conditions on the intermolecular interaction between insulin and cell-penetrating peptide penetratin and on its contribution to stimulation of permeation through intestinal epithelium.
    Kamei N; Aoyama Y; Khafagy el-S; Henmi M; Takeda-Morishita M
    Eur J Pharm Biopharm; 2015 Aug; 94():42-51. PubMed ID: 25960330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploration of the Key Factors for Optimizing the in Vivo Oral Delivery of Insulin by Using a Noncovalent Strategy with Cell-Penetrating Peptides.
    Kamei N; Shigei C; Hasegawa R; Takeda-Morishita M
    Biol Pharm Bull; 2018; 41(2):239-246. PubMed ID: 29386483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo proof of concept of oral insulin delivery based on a co-administration strategy with the cell-penetrating peptide penetratin.
    Nielsen EJ; Yoshida S; Kamei N; Iwamae R; Khafagy el-S; Olsen J; Rahbek UL; Pedersen BL; Takayama K; Takeda-Morishita M
    J Control Release; 2014 Sep; 189():19-24. PubMed ID: 24973720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of intestinal luminal contents and the importance of microfold cells on the ability of cell-penetrating peptides to enhance epithelial permeation of insulin.
    Kamei N; Kawano S; Abe R; Hirano S; Ogino H; Tamiwa H; Takeda-Morishita M
    Eur J Pharm Biopharm; 2020 Oct; 155():77-87. PubMed ID: 32781024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic study of the uptake/permeation of cell-penetrating peptides across a caco-2 monolayer and their stimulatory effect on epithelial insulin transport.
    Kamei N; Onuki Y; Takayama K; Takeda-Morishita M
    J Pharm Sci; 2013 Nov; 102(11):3998-4008. PubMed ID: 23963728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of cell-penetrating peptides to improve intestinal insulin absorption.
    Kamei N; Morishita M; Eda Y; Ida N; Nishio R; Takayama K
    J Control Release; 2008 Nov; 132(1):21-5. PubMed ID: 18727945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Penetratin-Mediated Transepithelial Insulin Permeation: Importance of Cationic Residues and pH for Complexation and Permeation.
    Kristensen M; Franzyk H; Klausen MT; Iversen A; Bahnsen JS; Skyggebjerg RB; Foderà V; Nielsen HM
    AAPS J; 2015 Sep; 17(5):1200-9. PubMed ID: 25990963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Penetratin derivative-based nanocomplexes for enhanced intestinal insulin delivery.
    Zhu X; Shan W; Zhang P; Jin Y; Guan S; Fan T; Yang Y; Zhou Z; Huang Y
    Mol Pharm; 2014 Jan; 11(1):317-28. PubMed ID: 24255985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Region-Dependent Role of Cell-Penetrating Peptides in Insulin Absorption Across the Rat Small Intestinal Membrane.
    Khafagy el-S; Iwamae R; Kamei N; Takeda-Morishita M
    AAPS J; 2015 Nov; 17(6):1427-37. PubMed ID: 26216471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applicability and Limitations of Cell-Penetrating Peptides in Noncovalent Mucosal Drug or Carrier Delivery Systems.
    Kamei N; Bech Nielsen EJ; Nakakubo T; Aoyama Y; Rahbek UL; Pedersen BL; Takeda-Morishita M
    J Pharm Sci; 2016 Feb; 105(2):747-753. PubMed ID: 26869427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dependence of Intestinal Absorption Profile of Insulin on Carrier Morphology Composed of β-Cyclodextrin-Grafted Chitosan.
    Daimon Y; Kamei N; Kawakami K; Takeda-Morishita M; Izawa H; Takechi-Haraya Y; Saito H; Sakai H; Abe M; Ariga K
    Mol Pharm; 2016 Dec; 13(12):4034-4042. PubMed ID: 27749081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Cell-Penetrating Peptides as Versatile, Effective Absorption Enhancers: Relation to Molecular Weight and Inherent Epithelial Drug Permeability.
    Kamei N; Yamanaka J; Oda Y; Kaneoka S; Koide Y; Haruna Y; Takahashi Y; Tamiwa H; Takeda-Morishita M
    Pharm Res; 2020 Sep; 37(10):182. PubMed ID: 32888051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-month subchronic toxicity study of cell-penetrating peptides for insulin nasal delivery in rats.
    Khafagy el-S; Kamei N; Nielsen EJ; Nishio R; Takeda-Morishita M
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):736-43. PubMed ID: 24060698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revealing the importance of carrier-cargo association in delivery of insulin and lipidated insulin.
    Diedrichsen RG; Harloff-Helleberg S; Werner U; Besenius M; Leberer E; Kristensen M; Nielsen HM
    J Control Release; 2021 Oct; 338():8-21. PubMed ID: 34298056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biorelevant dissolution media as a predictive tool for glyburide a class II drug.
    Wei H; Löbenberg R
    Eur J Pharm Sci; 2006 Sep; 29(1):45-52. PubMed ID: 16815694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microcontainers for oral insulin delivery - In vitro studies of permeation enhancement.
    Jørgensen JR; Jepsen ML; Nielsen LH; Dufva M; Nielsen HM; Rades T; Boisen A; Müllertz A
    Eur J Pharm Biopharm; 2019 Oct; 143():98-105. PubMed ID: 31425857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficiency of cell-penetrating peptides on the nasal and intestinal absorption of therapeutic peptides and proteins.
    Khafagy el-S; Morishita M; Kamei N; Eda Y; Ikeno Y; Takayama K
    Int J Pharm; 2009 Oct; 381(1):49-55. PubMed ID: 19646515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Charge-switchable zwitterionic polycarboxybetaine particle as an intestinal permeation enhancer for efficient oral insulin delivery.
    Li Y; Ji W; Peng H; Zhao R; Zhang T; Lu Z; Yang J; Liu R; Zhang X
    Theranostics; 2021; 11(9):4452-4466. PubMed ID: 33754071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visualization and Quantitative Assessment of the Brain Distribution of Insulin through Nose-to-Brain Delivery Based on the Cell-Penetrating Peptide Noncovalent Strategy.
    Kamei N; Shingaki T; Kanayama Y; Tanaka M; Zochi R; Hasegawa K; Watanabe Y; Takeda-Morishita M
    Mol Pharm; 2016 Mar; 13(3):1004-11. PubMed ID: 26795701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational design of polyarginine nanocapsules intended to help peptides overcoming intestinal barriers.
    Niu Z; Tedesco E; Benetti F; Mabondzo A; Montagner IM; Marigo I; Gonzalez-Touceda D; Tovar S; Diéguez C; Santander-Ortega MJ; Alonso MJ
    J Control Release; 2017 Oct; 263():4-17. PubMed ID: 28235590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.